The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

plausibounds: Plausible Bounds for Treatment Path Estimates

Enhances dynamic effect plots as suggested in Freyaldenhoven and Hansen (2026) <https://simonfreyaldenhoven.github.io/papers/Plausible_bounds.pdf>. Data-driven smoothing delivers a smooth estimated path with potentially improved point estimation properties and confidence regions covering a surrogate that can be substantially tighter than conventional pointwise or uniform bands.

Version: 1.0.1
Depends: R (≥ 3.5)
Imports: dplyr, ggplot2, Matrix, MASS, magrittr, cli
Suggests: knitr, rmarkdown, doParallel, foreach, testthat (≥ 3.0.0)
Published: 2026-01-20
DOI: 10.32614/CRAN.package.plausibounds (may not be active yet)
Author: Simon Freyaldenhoven [aut, cph], Christian Hansen [aut, cph], Ryan Kobler [aut, cre, cph]
Maintainer: Ryan Kobler <kobleary at gmail.com>
BugReports: https://github.com/SimonFreyaldenhoven/plausibounds/issues
License: MIT + file LICENSE
URL: https://github.com/SimonFreyaldenhoven/plausibounds
NeedsCompilation: no
Citation: plausibounds citation info
Materials: README, NEWS
CRAN checks: plausibounds results

Documentation:

Reference manual: plausibounds.html , plausibounds.pdf
Vignettes: Introduction to plausibounds (source)

Downloads:

Package source: plausibounds_1.0.1.tar.gz
Windows binaries: r-devel: not available, r-release: not available, r-oldrel: not available
macOS binaries: r-release (arm64): plausibounds_1.0.1.tgz, r-oldrel (arm64): plausibounds_1.0.1.tgz, r-release (x86_64): plausibounds_1.0.1.tgz, r-oldrel (x86_64): plausibounds_1.0.1.tgz

Linking:

Please use the canonical form https://CRAN.R-project.org/package=plausibounds to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.